Chemoinformaics analysis of 1,1-Diethoxynonane
| Molecular Weight | 216.365 | nRot | 11 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 0 |
| Exact Molecular Weight | 216.209 | nRing | 0 |
| Solubility: LogS | -4.439 | nHRing | 0 |
| Solubility: LogP | 4.637 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.9842 |
| nHD | 0 | BPOL | 31.5618 |
| QED | 0.382 |
| Synth | 2.155 |
| Natural Product Likeliness | 0.317 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.069 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.326 |
| MDCK | 0.0000253 |
| BBB | 0.197 |
| PPB | 0.95473 |
| VDSS | 1.413 |
| FU | 0.0357638 |
| CYP1A2-inh | 0.173 |
| CYP1A2-sub | 0.725 |
| CYP2c19-inh | 0.627 |
| CYP2c19-sub | 0.793 |
| CYP2c9-inh | 0.444 |
| CYP2c9-sub | 0.452 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.092 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.135 |
| CL | 9.675 |
| T12 | 0.184 |
| hERG | 0.084 |
| Ames | 0.005 |
| ROA | 0.014 |
| SkinSen | 0.662 |
| Carcinogencity | 0.066 |
| EI | 0.915 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.757839 |